- Report
- January 2025
- 132 Pages
Global
From €863EUR$950USD£739GBP
- Report
- January 2025
- 24 Pages
Singapore
From €995EUR$1,173USD£882GBP
- Report
- November 2024
- 26 Pages
Austria
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 22 Pages
Indonesia
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 21 Pages
Romania
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 23 Pages
Cameroon
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 22 Pages
North Macedonia
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 20 Pages
Tunisia
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 25 Pages
Poland
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 22 Pages
Pakistan
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 24 Pages
South Africa
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 24 Pages
Switzerland
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 23 Pages
Kenya
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 24 Pages
Turkey
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 20 Pages
Serbia
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 21 Pages
Slovenia
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 23 Pages
Sweden
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 21 Pages
Uzbekistan
From €995EUR$1,173USD£882GBP
- Report
- October 2024
- 23 Pages
Morocco
From €995EUR$1,173USD£882GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more